Recombinant multi-species Adiponectin/ADIPOQ protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Adiponectin/ADIPOQ protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Apr 2010]
The Alternative Names of target: 30 kDa adipocyte complement-related protein,30kDa,ACDC,ACRP30,ADID,ADIPOQ,ADIPQTL1,ADPN,APM-1,APM1,APN,Acdc,Acrp30,Ad,Adid,Adipocyte,Adipocyte complement-related 30 kDa protein (ACRP30),Adiponectin,Adipoq,Adipose most abundant gene transcript 1 protein (apM-1),C1q and collagen domain-containing protein,GBP28,Gelatin-binding protein,adipo,apM1

Target products collectionGo to Adiponectin/ADIPOQ products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T15572-Ag-1/ GM-Tg-hg-T15572-Ag-2 Human Adiponectin/ADIPOQ protein Human
GM-Tg-rg-T15572-Ag-1/ GM-Tg-rg-T15572-Ag-2 Rat Adiponectin/ADIPOQ protein Rat
GM-Tg-mg-T15572-Ag-1/ GM-Tg-mg-T15572-Ag-2 Mouse Adiponectin/ADIPOQ protein Mouse
GM-Tg-cynog-T15572-Ag-1/ GM-Tg-cynog-T15572-Ag-2 Cynomolgus/Rhesus macaque Adiponectin/ADIPOQ protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T15572-Ag-1/ GM-Tg-felg-T15572-Ag-2 Feline Adiponectin/ADIPOQ protein Feline
GM-Tg-cang-T15572-Ag-1/ GM-Tg-cang-T15572-Ag-2 Canine Adiponectin/ADIPOQ protein Canine
GM-Tg-bovg-T15572-Ag-1/ GM-Tg-bovg-T15572-Ag-2 Bovine Adiponectin/ADIPOQ protein Bovine
GM-Tg-equg-T15572-Ag-1/ GM-Tg-equg-T15572-Ag-2 Equine Adiponectin/ADIPOQ protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T15572-Ag-1/ GM-Tg-hg-T15572-Ag-2; GM-Tg-rg-T15572-Ag-1/ GM-Tg-rg-T15572-Ag-2;
GM-Tg-mg-T15572-Ag-1/ GM-Tg-mg-T15572-Ag-2; GM-Tg-cynog-T15572-Ag-1/ GM-Tg-cynog-T15572-Ag-2;
GM-Tg-felg-T15572-Ag-1/ GM-Tg-felg-T15572-Ag-2; GM-Tg-cang-T15572-Ag-1/ GM-Tg-cang-T15572-Ag-2;
GM-Tg-bovg-T15572-Ag-1/ GM-Tg-bovg-T15572-Ag-2; GM-Tg-equg-T15572-Ag-1/ GM-Tg-equg-T15572-Ag-2
Products Name Adiponectin/ADIPOQ protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Adiponectin/ADIPOQ
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Adiponectin/ADIPOQ protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.